255 related articles for article (PubMed ID: 28249898)
1. Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.
Ibrahim-Hashim A; Robertson-Tessi M; Enriquez-Navas PM; Damaghi M; Balagurunathan Y; Wojtkowiak JW; Russell S; Yoonseok K; Lloyd MC; Bui MM; Brown JS; Anderson ARA; Gillies RJ; Gatenby RA
Cancer Res; 2017 May; 77(9):2242-2254. PubMed ID: 28249898
[TBL] [Abstract][Full Text] [Related]
2. Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces.
Lloyd MC; Cunningham JJ; Bui MM; Gillies RJ; Brown JS; Gatenby RA
Cancer Res; 2016 Jun; 76(11):3136-44. PubMed ID: 27009166
[TBL] [Abstract][Full Text] [Related]
3. Adaptive therapy.
Gatenby RA; Silva AS; Gillies RJ; Frieden BR
Cancer Res; 2009 Jun; 69(11):4894-903. PubMed ID: 19487300
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
5. The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.
Kim H; Lin Q; Glazer PM; Yun Z
Breast Cancer Res; 2018 Mar; 20(1):16. PubMed ID: 29510720
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
[TBL] [Abstract][Full Text] [Related]
7. Adaptation to Stochastic Temporal Variations in Intratumoral Blood Flow: The Warburg Effect as a Bet Hedging Strategy.
Gravenmier CA; Siddique M; Gatenby RA
Bull Math Biol; 2018 May; 80(5):954-970. PubMed ID: 28508297
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
[TBL] [Abstract][Full Text] [Related]
9. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.
Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Halabi N; Guerrouahen BS; Rafii S; Rafii A
J Transl Med; 2015 Jan; 13():27. PubMed ID: 25623554
[TBL] [Abstract][Full Text] [Related]
12. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
13. Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice.
Astigiano S; Puglisi A; Mastracci L; Fais S; Barbieri O
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):363-368. PubMed ID: 28095711
[TBL] [Abstract][Full Text] [Related]
14. Targeting of Evolutionarily Acquired Cancer Cell Phenotype by Exploiting pHi-Metabolic Vulnerabilities.
Ordway B; Tomaszewski M; Byrne S; Abrahams D; Swietach P; Gillies RJ; Damaghi M
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33379345
[TBL] [Abstract][Full Text] [Related]
15. Vascular measurements correlate with estrogen receptor status.
Lloyd MC; Alfarouk KO; Verduzco D; Bui MM; Gillies RJ; Ibrahim ME; Brown JS; Gatenby RA
BMC Cancer; 2014 Apr; 14():279. PubMed ID: 24755315
[TBL] [Abstract][Full Text] [Related]
16. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby RA; Gawlinski ET
Cancer Res; 2003 Jul; 63(14):3847-54. PubMed ID: 12873971
[TBL] [Abstract][Full Text] [Related]
17. Genomic pathways modulated by Twist in breast cancer.
Vesuna F; Bergman Y; Raman V
BMC Cancer; 2017 Jan; 17(1):52. PubMed ID: 28086829
[TBL] [Abstract][Full Text] [Related]
18. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
19. P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Oncol Rep; 2015 Jul; 34(1):195-202. PubMed ID: 26063340
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells.
Kumar S; Eroglu E; Stokes JA; Scissum-Gunn K; Saldanha SN; Singh UP; Manne U; Ponnazhagan S; Mishra MK
Oncotarget; 2017 Mar; 8(13):20895-20908. PubMed ID: 28157696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
